NASDAQ:IKNA
Ikena Oncology, Inc.
- Stock
Last Close
1.32
03/05 20:00
Market Cap
63.70M
Beta: 0.75
Volume Today
367.59K
Avg: 63.66K
PE Ratio
−0.98
PFCF: −0.87
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 1.53M - | 2.25M 47.40% | 2.24M 0.64% | 2.08M 7.10% | ||
average receivables | ||||||
book value per share | -4.39 - | -2.92 33.51% | 7.43 354.28% | 4.06 45.33% | 0.00 99.90% | |
capex per share | -0.02 - | -0.02 1.97% | -0.06 183.99% | -0.04 37.13% | -0.00 99.97% | |
capex to depreciation | -1.30 - | -2.55 96.35% | -3.24 26.71% | -1.91 41.10% | -0.41 78.70% | |
capex to operating cash flow | -0.01 - | 0.02 407.14% | 0.03 44.25% | 0.02 33.90% | 0.01 73.11% | |
capex to revenue | -0.02 - | -0.08 262.61% | -0.06 31.82% | -0.09 61.31% | ||
cash per share | 5.87 - | 4.70 19.94% | 8.30 76.64% | 4.34 47.74% | 0.00 99.90% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.03 - | 0.00 96.29% | 0.03 2,451.69% | 0.03 17.29% | 0.06 69.11% | |
debt to equity | -0.04 - | -0.00 95.58% | 0.03 1,925.73% | 0.04 15.28% | 0.06 63.27% | |
dividend yield | ||||||
earnings yield | -0.04 - | -0.04 6.42% | -0.10 143.14% | -0.69 611.94% | -0.00 99.88% | |
enterprise value | 365.52M - | 944.51M 158.40% | 125.68M 86.69% | 42.04M 66.55% | 82.11B 195,229.17% | |
enterprise value over ebitda | -20.03 - | -21.36 6.64% | -3.74 82.49% | -0.60 83.98% | -1.09K 181,595.47% | |
ev to operating cash flow | 7.63 - | -24.97 427.41% | -2.09 91.65% | -0.57 72.81% | -1.03K 181,428.78% | |
ev to sales | 26.58 - | 102.73 286.54% | 4.06 96.05% | 2.69 33.64% | ||
free cash flow per share | 3.40 - | -1.12 132.78% | -2.22 98.61% | -2.09 5.80% | -0.00 99.91% | |
free cash flow yield | 0.11 - | -0.03 132.78% | -0.18 406.82% | -0.78 344.07% | -0.00 99.88% | |
graham net net | -4.67 - | -3.09 33.81% | 6.87 322.12% | 3.64 47.04% | 0.00 99.90% | |
graham number | 10.90 - | 9.17 15.88% | 14.27 55.65% | 12.97 9.14% | 0.01 99.91% | |
income quality | -2.85 - | 0.85 129.99% | 1.77 106.64% | 1.08 38.98% | 1.17 8.55% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -32.99 - | |||||
interest debt per share | 0.18 - | 0.01 97.06% | 0.25 4,542.38% | 0.22 13.19% | 0.00 99.88% | |
inventory turnover | ||||||
invested capital | -0.04 - | -0.00 95.58% | 0.03 1,925.73% | 0.04 15.28% | 0.06 63.27% | |
market cap | 447.60M - | 1.11B 147.28% | 350.91M 68.30% | 96.26M 72.57% | 82.22B 85,311.48% | |
net current asset value | -62.23M - | -103.48M 66.29% | 196.51M 289.90% | 134.72M 31.45% | 156.33M 16.04% | |
net debt to ebitda | 4.50 - | 3.67 18.40% | 6.70 82.66% | 0.77 88.47% | 1.45 87.25% | |
net income per share | -1.20 - | -1.28 6.42% | -1.22 4.72% | -1.84 51.02% | -0.00 99.91% | |
operating cash flow per share | 3.43 - | -1.09 131.92% | -2.15 96.88% | -2.05 4.89% | -0.00 99.91% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | 1.81 - | 4.88 169.01% | 1.52 68.83% | 4.12 170.88% | ||
return on tangible assets | -0.20 - | -0.26 34.35% | -0.14 47.63% | -0.39 181.03% | -0.35 8.25% | |
revenue per share | 0.98 - | 0.27 72.97% | 1.11 316.55% | 0.43 61.02% | ||
roe | 0.27 - | 0.44 60.07% | -0.16 137.47% | -0.45 176.24% | -0.40 11.42% | |
roic | 0.31 - | 0.44 40.86% | -0.15 134.80% | -0.43 181.92% | -0.40 8.88% | |
sales general and administrative to revenue | 0.53 - | 0.96 81.50% | 0.58 39.71% | 1.42 144.49% | ||
shareholders equity per share | -4.39 - | -2.92 33.51% | 7.43 354.28% | 4.06 45.33% | 0.00 99.90% | |
stock based compensation to revenue | 0.08 - | 0.20 129.95% | 0.17 14.52% | 0.48 188.37% | ||
tangible asset value | -61.46M - | -101.05M 64.40% | 207.88M 305.72% | 146.97M 29.30% | 169.76M 15.51% | |
tangible book value per share | -4.39 - | -2.92 33.51% | 7.43 354.28% | 4.06 45.33% | 0.00 99.90% | |
working capital | 60.91M - | 137.64M 125.98% | 209.33M 52.09% | 138.51M 33.83% | 164.46M 18.74% |
All numbers in USD (except ratios and percentages)